OPEN END-TURBO-OPTIONSSCHEIN - RESMED | Real-time Bid/Ask 04:19:26 06/06/2024 pm IST | ||
| 1.1 EUR / 1.27 EUR | +11.79% |
|
| Current month | +116.33% | ||
| 1 month | -34.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 06/24/06 | 1.11 | +4.72% |
| 05/24/05 | 1.06 | +15.22% |
| 04/24/04 | 0.92 | +64.29% |
| 03/24/03 | 0.56 | +14.29% |
| 31/24/31 | 0.49 | -40.96% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 03:12 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | HSBC |
| WKN | HS697J |
| ISIN | DE000HS697J6 |
| Date issued | 26/04/2024 |
| Strike | 203 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.94 € |
|---|---|
| Lowest since issue | 0.36 € |
| Spread | 0.17 € |
| Spread % | 13.39% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
213.2
USD
Average target price
218.7
USD
Spread / Average Target
+2.57%
- Stock Market
- Certificates
- Certificat
